A multitransmit external body array combined with a 1H and 31P endorectal coil to enable a multiparametric and multimetabolic MRI examination of the prostate at 7T.

Purpose: In vivo1H and 31P magnetic resonance spectroscopic imaging (MRSI) provide complementary information on the biology of prostate cancer. In this work we demonstrate the feasibility of performing multiparametric imaging (mpMRI) and 1H and 31P spectroscopic imaging of the prostate using a 31P and 1H endorectal radiofrequency coil (ERC) in combination with a multitransmit body array at 7 Tesla (T). Methods: An ERC with a 31P transceiver loop coil and 1H receive (Rx) asymmetric microstrip (31P/1H ERC) was designed, constructed and tested in combination with an external 8‐channel 1H transceiver body array coil (8CH). Electromagnetic field simulations and measurements and in vivo temperature measurements of the ERC were performed for safety validation. In addition, the signal‐to‐noise (SNR) benefit of the 1H microstrip with respect to the 8CH was evaluated. Finally, the feasibility of the setup was tested in one volunteer and three patients with prostate cancer by performing T2‐weighted and diffusion‐weighted imaging in combination with 1H and 31P spectroscopic imaging. Results: Electromagnetic field simulations of the 31P loop coil showed no differences in the E‐ and B‐fields of the 31P/1H ERC compared with a previously safety validated ERC without 1H microstrip. The hotspot of the specific absorption rate (SAR) at the feed point of the 31P/1H ERC loop coil was 9.42 W/kg when transmitting on 31P at 1 W. Additional in vivo measurements showed a maximum temperature increase at the SAR hotspot of 0.7°C over 6 min on 31P at 1.9 W transmit (Tx) power, indicating safe maximum power levels. When transmitting with the external 1H body array at 40W for 2:30 min, the temperature increase around the ERC was < 0.3°C. Up to 3.5 cm into the prostate the 1H microstrip of the ERC provided higher SNR than the 8CH. The total coil combination allowed acquisition of an mpMRI protocol and the assessment of 31P and 1H metabolites of the prostate in all test subjects. Conclusion: We developed a setup with a 31P transceiver and 1H Rx endorectal coil in combination with an 8‐channel transceiver external body array coil and demonstrated its safety and feasibility for obtaining multiparametric imaging and 1H and 31P MRSI at 7T in patients with prostate cancer within one MR examination. [ABSTRACT FROM AUTHOR]